Works matching DE "SMALL cell lung cancer"
Results: 4001
Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis.
- Published in:
- Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03157-1
- By:
- Publication type:
- Article
Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2025, v. 486, n. 2, p. 243, doi. 10.1007/s00428-024-03754-3
- By:
- Publication type:
- Article
β-elemene inhibits tumor-promoting in small cell lung cancer by affecting M2 macrophages and TGF-β.
- Published in:
- BMC Pulmonary Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12890-025-03533-z
- By:
- Publication type:
- Article
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung Carcinoma.
- Published in:
- Lung, 2025, v. 203, n. 1, p. 1, doi. 10.1007/s00408-025-00793-8
- By:
- Publication type:
- Article
Causal relationship between hormone levels and lung cancer: a Mendelian randomization study.
- Published in:
- Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1462531
- By:
- Publication type:
- Article
Current Development of Therapeutic Vaccines in Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 185, doi. 10.3390/vaccines13020185
- By:
- Publication type:
- Article
Current Development of Therapeutic Vaccines in Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 185, doi. 10.3390/vaccines13020185
- By:
- Publication type:
- Article
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 401, doi. 10.3390/biomedicines13020401
- By:
- Publication type:
- Article
Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03958-9
- By:
- Publication type:
- Article
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04760-1
- By:
- Publication type:
- Article
Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor.
- Published in:
- Genome Medicine, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13073-025-01438-4
- By:
- Publication type:
- Article
SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO OPTED OUT OF CANCER-SPECIFIC THERAPY.
- Published in:
- Malaysian Journal of Medical Sciences, 2006, v. 13, n. 2, p. 24
- By:
- Publication type:
- Article
Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2012, v. 124, n. 7/8, p. 276, doi. 10.1007/s00508-012-0151-z
- By:
- Publication type:
- Article
XQ2, a Novel TPZ Derivative, Induced G2/M Phase Arrest and Apoptosis under Hypoxia in Non-Small Cell Lung Cancer. Cells.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 6, p. 1181, doi. 10.1271/bbb.90889
- By:
- Publication type:
- Article
Adenovirus-Mediated Suicide SCLC Gene Therapy Using the Increased Activity of the hTERT Promoter by the MMRE and SV40 Enhancer.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2005, v. 69, n. 1, p. 56, doi. 10.1271/bbb.69.56
- By:
- Publication type:
- Article
Endobronchial ultrasound-guided transbronchial needle aspiration in patients with previously treated lung cancer.
- Published in:
- Surgery Today, 2021, v. 51, n. 3, p. 415, doi. 10.1007/s00595-020-02101-8
- By:
- Publication type:
- Article
Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
- Published in:
- Surgery Today, 2017, v. 47, n. 12, p. 1476, doi. 10.1007/s00595-017-1536-4
- By:
- Publication type:
- Article
Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer?
- Published in:
- Surgery Today, 2017, v. 47, n. 4, p. 463, doi. 10.1007/s00595-016-1387-4
- By:
- Publication type:
- Article
Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
- Published in:
- Histochemistry & Cell Biology, 2020, v. 153, n. 6, p. 443, doi. 10.1007/s00418-020-01863-z
- By:
- Publication type:
- Article
The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation.
- Published in:
- Histochemistry & Cell Biology, 2012, v. 137, n. 5, p. 687, doi. 10.1007/s00418-012-0916-5
- By:
- Publication type:
- Article
Adhesion of small cell lung cancer cells to E- and P-Selectin under physiological flow conditions: implications for metastasis formation.
- Published in:
- Histochemistry & Cell Biology, 2011, v. 135, n. 5, p. 499, doi. 10.1007/s00418-011-0804-4
- By:
- Publication type:
- Article
UVA1-induced decrease in dermal neuron-specific enolase (NSE) in acrosclerosis.
- Published in:
- Archives of Dermatological Research, 2004, v. 296, n. 4, p. 182, doi. 10.1007/s00403-004-0495-y
- By:
- Publication type:
- Article
Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Preparation irinotecan hydrochloride loaded PEGylated liposomes using novel method supercritical fluid and condition optimized by Box–Behnken design.
- Published in:
- Discover Nano, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s11671-024-04071-z
- By:
- Publication type:
- Article
Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer.
- Published in:
- Bagcilar Medical Bulletin / Bağcılar Tıp Bülteni, 2022, v. 7, n. 2, p. 130, doi. 10.4274/BMB.galenos.2022.2021-09-098
- By:
- Publication type:
- Article
Paraneoplastic Cushing Syndrome and Membranous Glomerulonephritis Associated with Small Cell Lung Cancer.
- Published in:
- Türkiye Klinikleri Journal of Case Reports, 2021, v. 29, n. 4, p. 213, doi. 10.5336/caserep.2020-73346
- By:
- Publication type:
- Article
A Typical Review of Lung Cancer: Epidemiology, Diagnosis, Treatment, and Risk Factors.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Efficacy and safety of veliparib combined with traditional chemotherapy for treating patients with lung cancer: a comprehensive review and meta-analysis.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16402
- By:
- Publication type:
- Article
Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15357
- By:
- Publication type:
- Article
Comparative proteogenomics profiling of non-small and small lung carcinoma cell lines using mass spectrometry.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.8779
- By:
- Publication type:
- Article
Biomarker potential of repetitive-element transcriptome in lung cancer.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.8277
- By:
- Publication type:
- Article
Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.8163
- By:
- Publication type:
- Article
Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.7232
- By:
- Publication type:
- Article
Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 4, p. 1, doi. 10.1093/jnci/djv004
- By:
- Publication type:
- Article
Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non–Small Cell Lung Cancer Cells.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju204
- By:
- Publication type:
- Article
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 595, doi. 10.1093/jnci/djt072
- By:
- Publication type:
- Article
PDQ (Physician Data Query).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 19, p. 1431, doi. 10.1093/jnci/djs431
- Publication type:
- Article
Predictors and Outcomes of Limited Resection for Early-Stage Non–Small Cell Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 21, p. 1621, doi. 10.1093/jnci/djr387
- By:
- Publication type:
- Article
Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 19, p. 1452, doi. 10.1093/jnci/djr325
- By:
- Publication type:
- Article
Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 10, p. 817, doi. 10.1093/jnci/djr075
- By:
- Publication type:
- Article
ARRB1-Mediated Regulation of E2F Target Genes in Nicotine-Induced Growth of Lung Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 4, p. 317, doi. 10.1093/jnci/djq541
- By:
- Publication type:
- Article
The Challenge of Rational Development of Complex Natural Products as Cancer Therapeutics.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Gene Expression–Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 7, p. 464, doi. 10.1093/jnci/djq025
- By:
- Publication type:
- Article
Gene Expression-Based Prognostic Signatures in Lung Cancer Not Ready for Clinical Use.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 7, p. NP, doi. 10.1093/jnci/djq075
- Publication type:
- Article
Economics and the New Generation of Targeted Therapies for Non–Small Cell Lung Cancer.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Economic Analysis: Erlotinib Marginally Cost-Effective.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 5, p. NP, doi. 10.1093/jnci/djq023
- Publication type:
- Article
IN THIS ISSUE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 5, p. 285, doi. 10.1093/jnci/djq050
- Publication type:
- Article
Response: Re: Anti-Angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 23, p. 1657, doi. 10.1093/jnci/djp373
- By:
- Publication type:
- Article
Response: Re: Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 23, p. 1656, doi. 10.1093/jnci/djp375
- By:
- Publication type:
- Article
Thalidomide in Small Cell Lung Cancer: Wrong Drug or Wrong Disease?
- Published in:
- 2009
- By:
- Publication type:
- Editorial